Actionable news
0
All posts from Actionable news
Actionable news in ARWR: Arrowhead Research Corporation,

Arrowhead Pharmaceuticals to Present at Upcoming May Conferences

ARWR, -2.20% today announced that the company will make presentations at the following upcoming events.

Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease (ATVB|PVD) 2016 Scientific Sessions – Nashville, May 5-7, 2016

May 6, 11:00 a.m. CDT – Stacey Melquist, Ph.D., Arrowhead senior scientist, and coauthors, will deliver a poster presentation titled, “Lipoprotein(a) targeting with RNAi delivery platforms in transgenic mice and cynomolgus monkeys” (Presentation Number 428)

IBC’s 18 [th] Annual TIDES: Oligonucleotide and Peptide Therapeutics – Long Beach, California, May 9-12, 2016

May 9, 1:30 p.m. PDT – David Rozema, Ph.D., Arrowhead vice president of chemistry will deliver an oral presentation titled, “Protease-sensitive endosomal escape for delivery of siRNA in vivo

May 9, 1:30 p.m. PDT – Qingguo Tian, Ph.D., Arrowhead bioanalytical project manager will deliver an oral presentation titled, “Sensitive and specific quantification of oligonucleotides in biological matrices using hybridization based LC-fluorescence assays

5th Asian Conference on Hepatitis and AIDS (ACHA) – Nanjing, China, May 28-29, 2016

May 29, 4:50 p.m. CST (China Standard Tim) – Bruce Given, M.D., Arrowhead chief operating officer will deliver an oral presentation titled, “RNAi therapeutics for chronic HBV - Animal...


More